Variable | Level | N | Mean | SD |
---|---|---|---|---|
Age at data extraction or death | 178 | 65.83 | 9.35 | |
Age at initial BC diagnosis | 178 | 61.49 | 9.69 | |
Age at progression to metastatic disease | 178 | 62.85 | 9.39 | |
n | % | |||
Stage at diagnosis | Early (Stage IA, IB, IIA, IIB) | 40 | 22.5% | |
Limited Regional (Stage IIIA) | 8 | 4.5% | ||
Locally Advanced (Stage IIIB) | 6 | 3.4% | ||
Locally Advanced (Stage IIIC) | 5 | 2.8% | ||
Metastatic (Stage IV) | 119 | 66.9% | ||
ECOG performance status at the time of diagnosis of mBCa | 0 | 63 | 35.4% | |
1 | 96 | 53.9% | ||
2 | 18 | 10.1% | ||
3 | 1 | 0.6% | ||
Adjuvant treatment received (history) | Yes | 65 | 36.5% | |
No | 111 | 62.4% | ||
Don’t know | 2 | 1.1% |